Furthermore, the mechanism of LIMK1 increase induced by EA treatment may be associated with miR-134, which is localized in hippocampal CA1, by negatively regulating LIMK1 to enhance synaptic-dendritic plasticity in the recovery stage of ischemic stroke. This evidence concerns the gene LIMK1 and ischemic stroke.